Instrument Inactif

Autres langues Urologix Inc Nasdaq

Actions

US9172731047

Services et équipements d'exploitation minière

Cours en clôture Nasdaq
- ^USD	-

12/05/15	Transcript : Urologix, Inc., Q3 2015 Earnings Call, May 12, 2015
05/02/15	Transcript : Urologix, Inc., Q2 2015 Earnings Call, Feb 05, 2015

Autres langues

02/02/16	A unknown buyer acquired substantially all of the operating assets of Urologix, Inc.
09/07/15	Urologix Conducting A Strategic Review
12/05/15	Urologix, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2015
23/03/15	Urologix, Inc. Appoints Scott M. Madson as Chief Financial Officer Effective April 1, 2015
05/02/15	Urologix, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2014
12/01/15	Urologix, Inc. Announces Revenue Guidance for Second Quarter Ended on December 31, 2014
04/11/14	Urologix, Inc. Reports Unaudited Earnings Results for the First Quarter Ended September 30, 2014; Provides Cash Flow Guidance for the Fiscal 2015
19/08/14	Urologix, Inc. Announces Executive Changes
19/08/14	Urologix, Inc. Reports Unaudited Earnings Results for the Fourth Quarter and Year Ended June 30, 2014; Reports Impairment of Goodwill for the Second Quarter Ended June 30, 2014; Provides Earnings Guidance for the Full Year 2015
28/05/14	Urologix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014
06/05/14	Urologix, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014
10/04/14	Urologix, Inc. Announces Preliminary Unaudited Revenue Results for the Third Quarter Ended March 31, 2014
04/02/14	Urologix Secures Extension of Credit Facility
04/02/14	Urologix, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2013
08/01/14	Urologix, Inc. Reports Revenue Results for the Second Quarter Ended December 31, 2013; Withdraws Previously Issued Fiscal Year 2014 Revenue Guidance
29/10/13	Urologix, Inc. Announces Unaudited Earnings Results for the First Quarter Ended September 30, 2013; Reaffirms Revenue Guidance for Fiscal 2014
20/08/13	Urologix, Inc. Reports Unaudited Earnings Results for the Fourth Quarter and Year Ended June 30, 2013; Provides Revenue Guidance for the Fiscal Year 2014; Reports Impairment Charges for the Fourth Quarter Ended June 30, 2013
20/08/13	Urologix, Inc. completed the acquisition of certain assets and Licenses related to Prostiva business from Medtronic VidaMed, Inc.
01/07/13	Urologix, Inc. Reports Revenue Results for the Fourth Quarter and Full Year of Fiscal 2013
07/06/13	Urologix, Inc. Primary Exchange Listing will Change to OTCQB Marketplace from Nasdaq Capital Market
06/06/13	Urologix, Inc.(OTCPK:ULGX) dropped from NASDAQ Composite Index
01/05/13	Urologix, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2013; Reaffirms Revenue Guidance for Fiscal 2013
05/02/13	Urologix, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2012; Reaffirms Earnings Guidance for the Full Year of Fiscal 2013
30/01/13	Urologix, Inc. Appoints Gregory J. Fluet as Chief Executive Officer and Director
26/12/12	Certain shares of Urologix, Inc.'s Common Stock are subject to a Lock-Up Agreement Ending on 26-DEC-2012.